Reaction
Stoma Site Haemorrhage reporting signals
As of the last recalculation, Stoma Site Haemorrhage appears in 1,502 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is TEDUGLUTIDE (PRR 131.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Teduglutide | 118 | 131.6 | 132.8 |
| Carbidopa And Levodopa | 182 | 60.3 | 60.6 |
| Rotigotine | 40 | 39.3 | 39.5 |
| Trifluridine And Tipiracil | 28 | 36.8 | 36.9 |
| Rasagiline Mesylate | 27 | 34.2 | 34.3 |
| Amantadine | 34 | 31.1 | 31.2 |
| Rivastigmine | 32 | 24.0 | 24.1 |
| Ropinirole | 26 | 23.9 | 23.9 |
| Levodopa | 19 | 22.1 | 22.1 |
| Pramipexole | 22 | 20.2 | 20.2 |
| Regorafenib | 12 | 14.4 | 14.4 |
| Memantine | 14 | 14.3 | 14.3 |
| Memantine Hydrochloride | 14 | 14.3 | 14.3 |
| Irinotecan Hydrochloride | 13 | 14.1 | 14.1 |
| Oxaliplatin | 72 | 14.1 | 14.1 |
| Panitumumab | 15 | 13.4 | 13.4 |
| Donepezil Hydrochloride | 31 | 11.9 | 11.9 |
| Bevacizumab | 92 | 10.9 | 10.9 |
| Leucovorin Calcium | 14 | 10.2 | 10.2 |
| Fluorouracil Cream, 0.5% | 46 | 8.6 | 8.6 |
| Fluorouracil | 46 | 8.5 | 8.5 |
| Vedolizumab | 44 | 7.3 | 7.3 |
| Mirabegron | 20 | 7.2 | 7.2 |
| Capecitabine | 44 | 6.8 | 6.8 |
| Risankizumab-Rzaa | 36 | 6.2 | 6.2 |
| Cetuximab | 13 | 5.8 | 5.8 |
| Rivaroxaban | 82 | 5.7 | 5.7 |
| Encorafenib | 4 | 5.6 | 5.6 |
| Aflibercept | 11 | 4.9 | 4.9 |
| Rucaparib | 3 | 4.7 | 4.7 |
| Droxidopa | 6 | 3.9 | 3.9 |
| Pimavanserin Tartrate | 7 | 1.8 | 1.8 |